Expression and prognostic value of lactoferrin mRNA isoforms in human breast cancer

International Journal of Cancer

Volumn 114, Issue 2, 2005, Pages 299-306

  Benaïssa, Monique ^a   Peyrat, Jean Philippe ^b   Hornez, Louis ^b   Mariller, Christophe ^a   Mazurier, Joël ^a   Pierce, Annick ^a  

^a UNIVERSITÉ DES SCIENCES ET TECHNOLOGIES DE LILLE   (France)

^b CENTRE OSCAR LAMBRET   (France)

Author keywords

lactoferrin; Breast cancer; Lactoferrin; Mammary gland; Overall survival; Prognostic value; Relapse free survival

Indexed keywords

DELTA LACTOFERRIN; GENE PRODUCT; ISOPROTEIN; LACTOFERRIN; MESSENGER RNA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREAST BIOPSY; BREAST CANCER; BREAST CARCINOGENESIS; BREAST EPITHELIUM; BREAST LOBULAR CARCINOMA; CANCER CELL CULTURE; CANCER SURVIVAL; CELL STRAIN BT 20; CELL STRAIN HBL 100; CELL STRAIN MCF 7; CELL STRAIN MDA MB 231; CELL STRAIN T47D; EPITHELIUM CELL; GENE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LF GENE; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROGNOSIS; RELAPSE FREE SURVIVAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BASE SEQUENCE; BREAST NEOPLASMS; CELL LINE, TUMOR; DNA PRIMERS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LACTOFERRIN; PROGNOSIS; PROTEIN ISOFORMS; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 13244259275     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.20728     Document Type: Article

References (53)

1. Tsuda H, Sekine K, Ushida Y, Kuhara T, Takasuka N, Iigo M, Han BS, Moore MA. Milk and dairy products in cancer prevention: focus on bovine lactoferrin. Mutat Res 2000;462:227-33.
2. McIntosh GH, Regester GO, Le Leu RK, Royle PJ, Smithers GW. Dairy proteins protect against dimethylhydrazine-induced intestinal cancers in rats. J Nutr 1995;125:809-16.
3. Hakkak R, Korourian S, Shelnutt SR, Lensing S, Ronis MJ, Badger TM. Diets containing whey proteins or soy protein isolate protect against 7,12-dimethylbenz(a)anthracene-induced mammary tumors in female rats. Cancer Epidemiol Biomarkers Prev 2000;9:113-7.
4. Nuijens JH, van Berkel PHC, Schanbacher FL. Structure and biological actions of lactoferrin. J Mamm Gland Biol Neoplas 1996;1:285-95.
5. Baveye S, Elass E, Mazurier J, Spik G, Legrand D. Lactoferrin: a multifunctional glycoprotein involved in the modulation of the inflammatory process. Clin Chem Lab Med 1999;37:281-6.
6. Brock JH. The physiology of lactoferrin. Biochem Cell Biol 2002;80:1-6.
7. Ward PP, Uribe-Luna S, Conneely, O. Lactoferrin and host defense. Biochem Cell Biol 2002;80:95-102.
8. Tsuda H, Sekine K, Fujita K, Ligo M. Cancer prevention by bovine lactoferrin and underlying mechanisms: a review of experimental and clinical studies. Biochem Cell Biol 2002;80:131-6.
9. Siebert PD, Huang BCB. Identification of an alternative form of human lactoferrin mRNA that is expressed differentially in normal tissues and tumor-derived cell lines. Proc Natl Acad Sci USA 1997;94:2189-203.
10. Liu D, Wang X, Zhang Z, Teng CT. An intronic alternative promoter of the human lactoferrin gene is activated by Ets. Biochem Biophys Res Commun 2003;301:472-9.
11. Breton M, Mariller C, Benaïssa M, Caillaux K, Browaeys E, Vilain J-P, Mazurier J, Pierce A. Expression of delta-lactoferrin induces cell cycle arrest. Biometals 2004;17:325-9.
12. Garre C, Bianchi-Scarra G, Sirito M, Musso M, Ravazzolo R. Lactoferrin binding sites and nuclear localization in K562 (S) cells. J Cell Physiol 1992;153:477-82.
13. Legrand D, Vigie K, Said EA, Elass E, Masson M, Slomianny MC, Carpentier M, Briand JP, Mazurier J, Hovanessian AG. Surface nucleolin participates in both the binding and endocytosis of lactoferrin in target cells. Eur J Biochem 2004;271:303-17.
14. Teng CT. Lactoferrin gene expression and regulation: an overview. Biochem Cell Biol 2002;80:7-16.
15. Masson PL, Heremans JF, Dive CH. An iron binding protein common to many external secretions. Clin Chim Acta 1966;14:735-9.
16. Montreuil J, Tonnelat J, Mullet J. Préparation et propriétés de la lactosidérophiline (lactotransferrine) du lait de femme. Biochim Biophys Acta 1960;45:413-21.
17. Campbell T, Skilton RA, Coombes RC, Shousha S, Graham MD, Luqmani YA. Isolation of a lactoferrin cDNA clone and its expression in human breast cancer. Br J Cancer 1992;65:19-26.
18. Masson PL, Heremans JF, Schönne E. Lactoferrin: an iron binding protein in neutrophilic leukocytes. J Exp Med 1969;130:643-58.
19. Fillebeen C, Ruchoux MM, Mitchell V, Vincent S, Benaïssa M, Pierce A. Lactoferrin is synthesized by activated microglia in the human substantia nigra and its synthesis by the human microglial CHME cell line is upregulated by tumor necrosis factor alpha or 1-methyl-4-phenylpyridinium treatment. Brain Res Mol Brain Res 2001;96:103-13.
20. Norrby K, Mattsby-Baltzer I, Innocenti M, Tuneberg S. Orally administered bovine lactoferrin systemically inhibits VEGF(165)-mediated angiogenesis in the rat. Int J Cancer 2001;91:236-40.
21. Bezault J, Bhimani R, Wiprovnick J, Furmanski P. Human lactoferrin inhibits growth of solid tumors and development of experimental metastases in mice. Cancer Res 1994;54:2310-2.
22. Iigo M, Kuhara T, Ushida Y, Sekine K, Moore MA, Tsuda H. Inhibitory effects of bovine lactoferrin on colon carcinoma 26 lung metastasis in mice. Clin Exp Metastasis 1999;17:35-40.
23. Damiens E, El Yazidi I, Mazurier J, Duthille I, Spik G, Boilly-Marer Y. Lactoferrin inhibits G1 cyclin-dependent kinases during growth arrest of human breast carcinoma cells. J Cell Biochem 1999;47:486-98.
24. Sekine K, Ushida Y, Kuhara T, Iigo M, Baba-Toriyama H, Moore MA, Murakoshi M, Satomi Y, Nishino H, Kakizoe T, Tsuda H. Inhibition of initiation and early stage development of aberrant crypt foci and enhanced natural killer activity in male rats administered bovine lactoferrin concomitantly with azoxymethane. Cancer Lett 1997;121:211-6.
25. Iigo M, Shimamura M, Matsuda E, Fujita K, Nomoto H, Satoh J, Kojima S, Alexander DB, Moore MA, Tsuda H. Orally administered bovine lactoferrin induces caspase-1 and interleukin-18 in the mouse intestinal mucosa: a possible explanation for inhibition of carcinogenesis and metastasis. Cytokine 2004;25:36-44.
26. Charpin C, Lachard A, Pourreau-Schneider N, Jacquemier J, Lavaut MN, Andonian C, Martin PM, Toga M. Localization of lactoferrin and nonspecific cross-reacting antigen in human breast carcinomas: an immunohistochemical study using the avidin-biotin-peroxidase complex method. Cancer 1985;55:2612-7.
27. Rado TA, Bollekens J, St Laurent G, Parker L, Benz EJ Jr. Lactoferrin biosynthesis during granulocytopoiesis. Blood 1984;64:1103-9.
28. Penco S, Caligo MA, Cipollini G, Bevilacqua G, Garre C. Lactoferrin expression in human breast cancer. Cancer Biochem Biophys 1999;17:163-78.
29. Panella TJ, Liu YH, Huang AT, Teng CT. Polymorphism and altered methylation of the lactoferrin gene in normal leukocytes, leukemic cells, and breast cancer. Cancer Res 1991;51:3037-43.
30. Teng CT, Gladwell W, Raphiou I, Liu E. Methylation and expression of the lactoferrin gene in human tissues and cancer cells, Biometals 2004;17:317-23.
31. Liu LE, Gladwell W, Teng CT. Detection of exon polymorphisms in the human lactoferrin gene. Biochem Cell Biol 2002;80:17-22.
32. Pawlowski V, Revillion F, Hebbar M, Hornez L, Peyrat JP. Prognostic value of the type I growth factor receptors in a large series of human primary breast cancers quantified with a real-time reverse transcription-polymerase chain reaction assay. Clin Cancer Res 2000;6:4217-25.
33. Recchi MA, Hebbar M, Hornez L, Harduin-Lepers A, Peyrat JP, Delannoy P. Multiplex reverse transcription polymerase chain reaction assessment of sialyltransferase expression in human breast cancer. Cancer Res 1998;58:4066-70.
34. Contesso G, Mouriesse H, Friedman S, Genin J, Sarrazin D, Rouesse J. The importance of histologic grade in long-term prognosis of breast cancer: a study of 1010 patients uniformly treated at Institut Gustave Roussy. J Clin Oncol 1987;5:1378-86.
35. Horwitz KB, McGuire WL. Specific progesterone receptors in human breast cancer. Steroids 1975;25:497-505.
36. Blankenstein MA. Comparison of ligand binding assay and enzyme immunoassay of estrogen receptor in human breast cancer cytosols: experience of the EORTC Receptor Group. Breast Cancer Res Treat 1990;17:91-8.
37. Bonneterre J, Peyrat JP, Beuscart R, Demaille A. Prognostic significance of insulin-like growth factor 1 receptors in human breast cancer. Cancer Res 1990;50:6931-5.
38. Pawlowski V, Révillion F, Hebbar M, Hornez L, Peyrat JP. Prognostic value of the type I growth factor receptors in a large series of human primary breast cancers with a real-time reverse transcription-polymerase chain reaction assay. Clin Cancer Res 2000;6:4217-25.
39. Dong-Le Bourhis X, Berthois Y, Millot G, Degeorges A, Sylvi M, Martin PM, Calvo F. Effect of stromal and epithelial cells derived from normal and tumorous breast tissue on the proliferation of human breast cancer cell lines in co-culture. Int J Cancer 1997;71:42-8.
40. Revillion F, Pawlowski V, Hornez L, Peyrat JP. Glyceraldehyde-3-phosphate dehydrogenase gene expression in human breast cancer. Eur J Cancer 2000;36:1038-42.
41. Cox DR. Regression models and lifetables. J R Stat Soc USA 1972;34:187-200.
42. de Arriba Zerpa GA, Saleh MC, Fernandez PM, Guillou F, Espinosa de los Monteras A, de Vellis J, Zakin MM, Baron B. Alternative splicing prevents transferrin secretion during differentiation of a human oligodendrocyte cell line. J Neurosci Res 2000;61:388-95.
43. He J, Furmanski P. Sequence specificity and transcriptional activation in the binding of lactoferrin toDNA. Nature 1995;373:721-4.
44. Huettinger M, Retzek H, Hermann M, Goldenberg H. Lactoferrin specifically inhibits endocytosis of chylomicron remnants but not alpha-macroglobulin. J Biol Chem 1992;267:18551-7.
45. Suzuki YA, Shin K, Lonnerdal B. Molecular cloning and functional expression of a human intestinal lactoferrin receptor. Biochemistry 2001;40:15771-9.
46. Damiens E, El Yazidi I, Mazurier J, Elass-Rochard E, Duthille I, Spik G, Boilly-Marer Y. Role of heparan sulphate proteoglycans in the regulation of human lactoferrin binding and activity in the MDA-MB-231 breast cancer cell line. Eur J Cell Biol 1998;77:344-51.
47. Fillebeen C, Descamps L, Dehouck MP, Fenart L, Benaïssa M, Spik G, Cecchelli R, Pierce A. Receptor-mediated transcytosis of lactoferrin through the blood-brain barrier. J Biol Chem 1999;274:7011-7.
48. Dhennin-Duthille I, Masson M, Damiens E, Fillebeen C, Spik G, Mazurier J. Lactoferrin upregulates the expression of CD4 antigen through the stimulation of the mitogen-activated protein kinase in the human lymphoblastic T Jurkat cell line. J Cell Biochem 2000;79:583-93.
49. Oh SM, Hahm DH, Kim IH, Choi SY. Human neutrophil lactoferrin trans-activates the matrix metalloproteinase 1 gene through stress-activated MAPK signaling modules. J Biol Chem 2001;276:42575-9.
50. Umayahara Y, Kawamori R, Watada H, Imano E, Iwama N, Morishima T, Yamasaki Y, Kajimoto Y, Kamada T. Estrogen regulation of the insulin-like growth factor I gene transcription involves an AP-1 enhancer. J Biol Chem 1994;269:16433-42.
51. Kurpios NA, Sabolic NA, Shepherd TG, Fidalgo GM, Hassell JA. Function of PEA3 Ets transcription factors in mammary gland development and oncogenesis. J Mamm Gland Biol Neoplas 2003;8:177-90.
52. Barrett JM, Puglia MA, Singh G, Tozer RG. Expression of Ets-related transcription factors and matrix metalloproteinase genes in human breast cancer cells. Breast Cancer Res Treat 2002;72:227-32.
53. Albright CD, Kaufman DG. Lactoferrin: a tamoxifen-responsive protein in normal and malignant human endometrial cells in culture. Exp Mol Pathol 2001;70:71-6.